Hippocampal Metabolic Alterations in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Spectroscopy Study
Life · 17.02.2023 · 13 (2) · 571
DOI: 10.3390/life13020571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 17.02.2023. Verfasst von Foteini Christidi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physics Laboratory, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU-IKY Scholarship Program (European Social Fund-ESF), Greece and the European Union (European Social Fund—ESF), Health Research Board.
Abstract (Originalsprache)
Background
Magnetic resonance spectroscopy (MRS) in amyotrophic lateral sclerosis (ALS) has been overwhelmingly applied to motor regions to date and our understanding of frontotemporal metabolic signatures is relatively limited. The association between metabolic alterations and cognitive performance in also poorly characterised. Material and Methods: In a multimodal, prospective pilot study, the structural, metabolic, and diffusivity profile of the hippocampus was systematically evaluated in patients with ALS. Patients underwent careful clinical and neurocognitive assessments. All patients were non-demented and exhibited normal memory performance. 1H-MRS spectra of the right and left hippocampi were acquired at 3.0T to determine the concentration of a panel of metabolites. The imaging protocol also included high-resolution T1-weighted structural imaging for subsequent hippocampal grey matter (GM) analyses and diffusion tensor imaging (DTI) for the tractographic evaluation of the integrity of the hippocampal perforant pathway zone (PPZ).
Results
ALS patients exhibited higher hippocampal tNAA, tNAA/tCr and tCho bilaterally, despite the absence of volumetric and PPZ diffusivity differences between the two groups. Furthermore, superior memory performance was associated with higher hippocampal tNAA/tCr bilaterally. Both longer symptom duration and greater functional disability correlated with higher tCho levels.
Conclusion
Hippocampal 1H-MRS may not only contribute to a better academic understanding of extra-motor disease burden in ALS, but given its sensitive correlations with validated clinical metrics, it may serve as practical biomarker for future clinical and clinical trial applications. Neuroimaging protocols in ALS should incorporate MRS in addition to standard structural, functional, and diffusion sequences.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Physics Laboratory, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
- First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
- Second Department of Psychiatry, Attikon General University Hospital, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece.
- School of Medicine, Democritus University of Thrace, 681 00 Alexandroupolis, Greece.
- Radiology Research Unit, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
- Department of Psychology, National and Kapodistrian University of Athens, 157 84 Athens, Greece.
ORCID-Profile: Efstratios Karavasilis, Georgios Velonakis, Panagiotis Kourtesis, Sofia Xirou
Förderung
- EU-IKY Scholarship Program (European Social Fund-ESF)
- Greece and the European Union (European Social Fund—ESF)
- Health Research Board
- Irish Institute of Clinical Neuroscience (IICN)
- Spastic Paraplegia Foundation (SPF)
- EU Joint Programme—Neurodegenerative Disease Research (JPND)
- Iris O’Brien Foundation
Zitieren
APA
Christidi, F., Argyropoulos, G. D., Karavasilis, E., Velonakis, G., Zouvelou, V., Kourtesis, P., Pantoleon, V., Tan, E. L., Daponte, A., Aristeidou, S., Xirou, S., Ferentinos, P., Evdokimidis, I., Rentzos, M., Seimenis, I., & Bede, P. (2023). Hippocampal Metabolic Alterations in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Spectroscopy Study. Life, 13(2), 571. https://doi.org/10.3390/life13020571
Vancouver
Christidi F, Argyropoulos GD, Karavasilis E, Velonakis G, Zouvelou V, Kourtesis P, et al. Hippocampal Metabolic Alterations in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Spectroscopy Study. Life. 2023;13(2):571. doi:10.3390/life13020571
BibTeX
@article{Christidi2023,
author = {Christidi, Foteini and Argyropoulos, Georgios D and Karavasilis, Efstratios and Velonakis, Georgios and Zouvelou, Vasiliki and Kourtesis, Panagiotis and Pantoleon, Varvara and Tan, Ee Ling and Daponte, Ariadne and Aristeidou, Stavroula and Xirou, Sofia and Ferentinos, Panagiotis and Evdokimidis, Ioannis and Rentzos, Michail and Seimenis, Ioannis and Bede, Peter},
title = {Hippocampal Metabolic Alterations in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Spectroscopy Study},
journal = {Life},
year = {2023},
volume = {13},
number = {2},
pages = {571},
doi = {10.3390/life13020571}
}
EUVIMED